Established in 2019, RDNZ's Round Table of Companies is a group of pharmaceutical companies with a common interest in rare disorders and orphan drug development.

The Round Table of Companies holds two meetings annually to discuss topics relevant to the development of orphan drugs and treatments for rare disorders in New Zealand. 

We welcome other pharmaceutical companies to join the Round Table of Companies if they have an interest in rare disorders and orphan drug development.

Please read our below policy documents and contact if your company would like to apply for membership.

RDNZ's Summary position statement on receiving funding from the pharmaceutical industry

RDNZ Working with Pharmaceutical Industry policy 2019

Membership benefits and requirements

RTC Memorandum of Understanding 2022


Current members:

Alexion logo
Amicus logo

Biogen logo
Biomarin logo  

MSD logo
Takeda logo Vertex logo